Mirador Capital Partners LP

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1633446 PLEASANTON, CA

Position in IOVA

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$4,493,998

+$726,940 QoQ

Shares Held

1,080,288

+0.7% QoQ

Ownership

0.238%

of shares outstanding

% of Portfolio

0.74%

of 13F equity value

Holder Rank

#42

of 289 holders

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mirador Capital Partners LP holds $31,412,059 across 6 Biotechnology names. IOVA ranks #3 (14.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CYTK	Cytokinetics Inc	202,370	$17,239,900
2	CLDX	Celldex Therapeutics, Inc.	181,054	$6,737,019
3	IOVA	Iovance Biotherapeutics, Inc. This page	1,080,288	$4,493,998
4	AKTS	Aktis Oncology, Inc.	40,124	$1,293,196
5	AXSM	Axsome Therapeutics, Inc.	4,000	$979,080
6	TNYA	Tenaya Therapeutics, Inc.	905,097	$668,866

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,493,998	1,080,288	+0.7%	Shares	Sole	2026-07-07
2026-03-31	$3,767,058	1,073,236	+3.7%	Shares	Sole	2026-04-08
2025-12-31	$2,824,305	1,034,544	+100.9%	Shares	Sole	2026-01-14
2025-09-30	$1,117,604	515,025	+711.3%	Shares	Sole	2025-10-07
2022-09-30	$608,128	63,479	-1.9%	Shares	Sole	2022-11-14
2022-06-30	$714,177	64,690	+50.1%	Shares	Sole	2022-08-05
2022-03-31	$717,698	43,105	+7.6%	Shares	Sole	2022-05-06
2021-12-31	$764,859	40,066	+58.4%	Shares	Sole	2022-02-02
2021-09-30	$623,750	25,294	+4.3%	Shares	Sole	2021-11-09
2021-06-30	$631,193	24,258	—	Shares	Sole	2021-07-27
No filing history on record for this holder in this stock.